ABEO
Abeona Therapeutics Inc
5.40$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 1.2% | 1,830.3% | 1,198.5% | 2,029.7% | 1,290.8% | – | 301.4% | 1,290.9% | 31.8% | 45.9% | – | 26.3% | |
| 100.0% | 100.0% | -1,098.5% | -1,929.7% | -1,190.8% | – | 100.0% | 100.0% | 68.2% | 54.1% | – | 73.7% | |
| 36.0% | 453.4% | 1,198.5% | 2,029.7% | 1,290.8% | – | 301.4% | 1,290.9% | 2,048.4% | 888.3% | – | 460.7% | |
| 401.3% | 1,376.9% | 1,494.9% | 1,307.4% | 670.6% | – | 237.8% | 721.5% | 1,220.4% | 543.0% | – | 1,117.4% | |
| 438.5% | 1,883.3% | 2,786.3% | 3,425.7% | 2,040.2% | – | 914.2% | 3,094.5% | 3,669.0% | 1,400.9% | – | 1,610.6% | |
| -338.5% | -1,783.3% | -2,686.3% | -3,325.7% | -1,940.2% | – | -814.2% | -2,994.5% | -3,600.8% | -1,346.7% | – | -1,536.9% | |
| 62.9% | 0.6% | 0.7% | 1.0% | 0.4% | – | 41.2% | 121.9% | 52.1% | 11.9% | – | 64.3% | |
| -2,894.9% | -1,396.7% | -2,460.4% | -3,263.9% | -1,890.3% | – | -842.3% | -2,831.2% | -2,807.4% | -1,548.2% | – | 1,224.8% | |
| 62.9% | 387.1% | 226.5% | 62.7% | 50.2% | – | 41.2% | 122.3% | -557.8% | 86.6% | – | 1.7% | |
| -2,894.9% | -1,396.7% | -2,460.4% | -3,263.9% | -1,890.3% | – | -842.3% | -2,831.2% | -2,807.4% | -1,548.2% | – | 1,223.1% | |
| -2,830.8% | -1,343.2% | -2,367.6% | -3,175.4% | -1,811.6% | – | -745.2% | -2,560.5% | -2,431.6% | -1,444.9% | – | 1,350.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.